{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6755a7397fbf90160675d4c9/6922f2349274ead23c91a8b2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Price of Life: How NICE Decides What Treatments NHS Can Afford","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6755a7397fbf90160675d4c9/1763897845349-e9d4d322-125c-4bb9-aef3-9c7e71050b24.jpeg?height=200","description":"<p>In this episode we look into one of the most influential but least understood institutions in British healthcare: NICE, the National Institute for Health and Care Excellence. We are joined by Dr Raju Reddy, Chair of one of NICE’s Technology Appraisal Committee. A consultant anaesthetist by training and MBA-qualified, Dr Reddy sits at the heart of decisions that affect billions of pounds in NHS spending — and, crucially, where that money is spent</p>","author_name":"Medstars"}